Outcome of 33rd Annaul general Meeting held on Saturday, September 26, 2026 at 12.00 Noon.

Ref: STEX/AGM/2026-27 26th September, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Department of Corporate Services - Listing Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai-400051 Dalal Street, Mumbai – 400 001 SYMBOL : MEDICAMEQ SCRIP CODE : 531146 Sub: Outcome/ Summary of proceedings of the 33rd Annual General Meeting of Medicamen Biotech Limited held on 26/09/2026 REF: Regulation 30, Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Dear Sir, Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to provide the proceedings of the 33rd Annual General Meeting of the Members of Medicamen Biotech Limited held on Saturday, 26th September, 2026 at 12.00 P.M. (IST) through two-way Video Conferencing (VQ) facility / Other Audio-Visual Means ('OAVM') in accordance with the applicable provisions of the Companies Act, 2013 read with the Rules issued thereunder and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the circulars issued by Ministry of Corporate Affairs and the Securities and Exchange Board of India. The proceedings of the AGM will also be hosted on the Company's website at https://www .medicamen.com/ We request you to take the same on record. Thanking You Yours truly, For Medicamen Biotech Limited Parul Choudhary Company Secretary ACS44157 SUMMARY OF PROCEEDINGS OF THE 33rd ANNUAL GENERAL MEETING OF MEDICAMEN BIOTECH LIMITED The 33rd Annual General Meeting (‘AGM’) of Medicamen Biotech Limited (‘the Company’) has been held today i.e. Saturday, September 26, 2026 at 12:00 P.M. (IST) through two-way Video Conferencing ("VC') facility / Other Audio-Visual Means (OAVM'). The meeting was held in compliance with General Circular No 11/2022 dated 28.12.2022, 20/2021 issued in continuation to MCA General Circular No. 14/2020 dated 8 April 2021 , 17/2020 dated 13 April 2020, 22/2020 dated 15 June 2020, 33/2020 dated 28 September, 2020 and 39/2020 dated 31 December 2020 and 10/2021 dated 23 June 2021 and 20/2021 dated December 08, 2021 in this regard and Circular SEBI/HO/CFD/CMD2/CIR/P/2022/62 dated May 13, 2022 issued by SEBI (hereinafter collectively referred to as the Circulars) along with applicable provisions of the Companies Act, 2013. The meeting commenced at 12.00 PM (IST). The Chairman of the company Mr Rahul Bishnoi took the chair and Ms. Parul Choudhary, Company Secretary and Compliance officer of the company welcomed the members in the meeting. She then introduced the members of the Board, KMP’s and the Secretarial Auditor. As the requisite quorum was present, She then requested the Chairman of the meeting to address the meeting and give his opening remarks. The Chairman then welcomed the Shareholders, Directors and Auditors to the meeting. As the requisite Quorum was present, he called the meeting to order and requested The Company Secretary and Compliance officer to proceed with the meeting. The Company Secretary and Compliance officer of the company informed the members that the Company had provided the remote e-voting facility to all the persons who were members as on the cut-off date i.e. Saturday 19th September, 2026 for voting on resolutions set out in the notice of AGM. The remote e-voting was kept open from 09:00 a.m. (IST) on Wednesday, 23rd September, 2026 and Upto 5.00 p.m. (IST) on Friday, 25th September, 2026. Members who have not cast their votes yet through remote e-voting facility and who are participating in this meeting can cast their vote during the AGM. All the documents referred to in the notice of AGM were made available for inspection. The Members were further informed that as the AGM is being held through video conferencing, the facility for appointment of proxies by the members is not applicable and hence the proxy register is not available for inspection. She further informed that M/s AMJ & Associates, Practicing Company Secretaries, has been appointed as the scrutinizer for the purpose of scrutinizing the E-voting and voting at the AGM. The E- voting results declared along with the Scrutinizer’s Report would be placed on the Company’s website, website of RTA i.e. MUFG Intime India Private Limited (formerly it is Link In Time India Private Limited) and the results would also be communicated to the Stock Exchange. The Company Secretary then informed that the Notice of the Annual General Meeting has already been sent by electronic mode to those Members whose e-mail addresses are registered with the Company or Depositories. The same has also been made available on the Company's website, website of RTA i.e MUFG Intime India Private Limited (formerly it is Link In Time India Private Limited) and on the website of the Stock Exchanges. She then informed that the notice convening the AGM of the Company was taken as read. She informed that there is no qualification, reservation or adverse remark in the Auditor's Report on the Financial Statements, hence were taken as read by the Chairman. He also informed that the Report of the Secretarial Auditor for the financial year ended 31st March, 2026, contains certain observations. The explanations and comments of the management in respect of the observations made by the Secretarial Auditor have been appropriately provided in the Board's Report She then read out the headings of the resolution items put to vote through remote e-voting and e-voting at the AGM: Ordinary Business: Item No 1: Ordinary Resolution To receive, consider and adopt the audited standalone financial statements of the company for the financial year ended 31 March 2026 and the reports of the board of directors and statutory auditor thereon Item No 2: Ordinary Resolution To receive, consider and adopt the audited consolidated financial statements of the company for the financial year ended 31 march 2026 and the report of the statutory auditor thereon Item No 3: Ordinary Resolution To declare dividend on Equity Shares. Item No 4: Ordinary Resolution To Re-appoint Mr Suresh Kumar Singh (DIN:00318015) as a director liable to retire by rotation Special Business: Item No 5: Ordinary Resolution To Re-appoint Mr Sanjay Bansal (DIN:00121667) as a director liable to retire by rotation Item No 6: Ordinary Resolution Ratification of remuneration of Cost Auditors Item No 7: Ordinary Resolution To approve material related party transactions with Shivalik Rasayan Limited (Holding Company) Item No 8: Ordinary Resolution To approve Material Related Party Transactions with Medicamen Life Sciences Private Limited (Subsidiary Company) Thereafter, she then allowed speaker shareholders to raise their queries/views one by one. The Members were given an opportunity to speak and appropriately response was given to the queries/suggestions raised by them. Chairman then thanked the Members, Board of Directors and the Auditors for their continued support and for attending the Meeting through VC/ OAVM. The e-voting facility was opened for members who have not voted through the remote evoting facility previously which commenced on Wednesday, September 23, 2026 at 9.00 a.m. (IST) till Saturday, September 25, 2026 upto 5.00 p.m. (IST) to cast their vote during and 15 minutes after the conclusion of the meeting to cast their vote on resolutions bearing from item no. 1 to item no. 8 as set forth in the Notice. The meeting was concluded at 12.45 P.M (IST). This is for your information and records. Thanking You Yours truly, For Medicamen Biotech Limited Parul Choudhary Company Secretary ACS44157